// App-Quantinova.ai

10503 : Adrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancer.

Researchers

Presenter

  • Nima Sharifi

Principal Investigators

  • Megan Lynn Kruse

  • Jeffrey McManus

  • Yoon-Mi Chung

  • Wei Wei

  • Peter Bazeley

  • Fumihiko Nakamura

  • Aimalie Hardaway

  • Erinn Downs Kelley

  • Sarat Chandarlapaty

  • Mathew Thomas

  • Halle C. F. Moore

  • George Thomas Budd

  • Wai Hong Wilson Tang

  • Stanley L. Hazen

  • Aaron Bernstein

  • Serena Nik-Zainal

  • Jame Abraham

Medical Centers

  • Cleveland Clinic, Cleveland, OH, Department of Hematology/Oncology, Cleveland Clinic, Cleveland, OH, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, Cleveland Clini, Cleveland, OH, Cleveland Clinic Foundation, Cleveland, OH, Memorial Sloan Kettering Cancer Center, New York, NY, Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, Cambridge University, Cambridge, United Kingdom

  • University of Cambridge, Cambridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • 3beta-hydroxysteroid dehydrogenase/delta(5)-delta(4)isomerase

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved